Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.
Takahiro KogawaTakeo FujiiTamer M FouadDiane D LiuKenichi HaranoHiroko MasudaToshiaki IwaseChad BarnettYoung Sam ParkBora LimDebu TripathyJennifer K LittonNaoto Tada UenoPublished in: Breast cancer research and treatment (2018)
Our data suggest that inability to maintain normal weight during NAC is a predictive marker of poor survival but not pCR. It may be important for patients to maintain a normal weight during NAC.
Keyphrases
- body mass index
- neoadjuvant chemotherapy
- end stage renal disease
- physical activity
- weight gain
- transcription factor
- weight loss
- locally advanced
- ejection fraction
- newly diagnosed
- lymph node
- chronic kidney disease
- prognostic factors
- sentinel lymph node
- peritoneal dialysis
- squamous cell carcinoma
- electronic health record
- machine learning
- radiation therapy
- deep learning
- childhood cancer